(August 30, 2016, 2:15 PM EDT) -- CHICAGO — Actavis PLC on Aug. 29 asked the testosterone replacement therapy multidistrict litigation court to reconsider its finding that Actavis engaged in racketeering with other defendants or, alternatively, to certify the issue for interlocutory appeal (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1749, Medical Mutual of Ohio v. AbbVie Inc., et al., No. 14-8857, N.D. Ill., Eastern Div.)....